Skip to content
Movie Casting Call
Author:
Lupin Pharmaceuticals, Inc.
Lupin Announces the Approval of Sodium Zirconium Cyclosilicate for Oral Suspension in the United States
August 10, 2026
Lupin Announces U.S. FDA Approval and Launch of Sugammadex Injection
July 30, 2026
Lupin Announces the Approval of Diazepam Injection, USP in the United States
July 28, 2026
Lupin Spins Out Two Oncology Programs to Kaveri Therapeutics to Advance its Oncology Strategy
July 21, 2026
Lupin Receives Tentative Approval from U.S. FDA for Enzalutamide Tablets
June 26, 2026
Lupin Launches Azilsartan Medoxomil Tablets in the United States
June 17, 2026